Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy

Abstract With the in-depth exploration on cancer therapeutic nanovaccines, increasing evidence shows that the poor delivery of nanovaccines to lymphoid organs has become the culprit limiting the rapid induction of anti-tumor immune response. Unlike the conventional prophylactic vaccines that mainly...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ting Cai, Huina Liu, Shun Zhang, Jing Hu, Lingxiao Zhang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/c8efa55ab0ae4d62b5de991db51d14d5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!